Sunflower announced that its subsidiary Zhejiang Beide Pharmaceutical Co., Ltd. participated in the centralized procurement of drugs in the Beijing-Tianjin-Hebei “3+N” Alliance, and the company's product Lacidipine dispersible tablets was selected.
向日葵：子公司参与药品集中采购中选
Sunflower: Subsidiaries participate in centralized drug procurement selection
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.